Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B McCray

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Genes|May 17, 2020
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung DiseaseMatthew D Strub, Paul B McCray
Ebiomedicine|July 7, 2020
Illuminating COVID-19 lung disease through autopsy studiesDavid K Meyerholz, Paul B McCray
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 29, 2012
Advances in cell and gene-based therapies for cystic fibrosis lung diseaseMayumi Oakland, Patrick L Sinn, Paul B McCray
The European Respiratory Journal|February 21, 2015
The innate immune function of airway epithelial cells in inflammatory lung diseasePieter S Hiemstra, Paul B McCray, Robert Bals
American Journal of Physiology. Cell Physiology|August 15, 2002
Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lungKenzo Nakamura, John B Stokes, Paul B McCray
Human Molecular Genetics|July 24, 2019
Advances in gene therapy for cystic fibrosis lung diseaseZiying Yan, Paul B McCray, John F Engelhardt
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection modelKaren H Bartlett, Paul B McCray, Peter S Thorne
Human Molecular Genetics|March 23, 2011
Genetic therapies for cystic fibrosis lung diseasePatrick L Sinn, Reshma M Anthony, Paul B McCray
Antibiotics (Basel, Switzerland)|March 31, 2016
NETs and CF Lung Disease: Current Status and Future ProspectsRobert D Gray, Brian N McCullagh, Paul B McCray
Genes|November 9, 2018
Cystic Fibrosis Gene Therapy: Looking Back, Looking ForwardAshley L Cooney, Paul B McCray, Patrick L Sinn
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Genes|May 17, 2020
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung DiseaseMatthew D Strub, Paul B McCray
Ebiomedicine|July 7, 2020
Illuminating COVID-19 lung disease through autopsy studiesDavid K Meyerholz, Paul B McCray
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 29, 2012
Advances in cell and gene-based therapies for cystic fibrosis lung diseaseMayumi Oakland, Patrick L Sinn, Paul B McCray
The European Respiratory Journal|February 21, 2015
The innate immune function of airway epithelial cells in inflammatory lung diseasePieter S Hiemstra, Paul B McCray, Robert Bals
American Journal of Physiology. Cell Physiology|August 15, 2002
Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lungKenzo Nakamura, John B Stokes, Paul B McCray
Human Molecular Genetics|July 24, 2019
Advances in gene therapy for cystic fibrosis lung diseaseZiying Yan, Paul B McCray, John F Engelhardt
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection modelKaren H Bartlett, Paul B McCray, Peter S Thorne
Human Molecular Genetics|March 23, 2011
Genetic therapies for cystic fibrosis lung diseasePatrick L Sinn, Reshma M Anthony, Paul B McCray
Antibiotics (Basel, Switzerland)|March 31, 2016
NETs and CF Lung Disease: Current Status and Future ProspectsRobert D Gray, Brian N McCullagh, Paul B McCray
Genes|November 9, 2018
Cystic Fibrosis Gene Therapy: Looking Back, Looking ForwardAshley L Cooney, Paul B McCray, Patrick L Sinn
Pageof 20